Why the study?
Human studies evaluate cardiac performance in non-sedated subjects, creating methodological challenges in murine HFpEF models where anesthetic choice may alter systolic, diastolic, and LA functional assessment.
Does the choice of anesthetic agent (isoflurane vs. Avertin) affect the echocardiographic evaluation of systolic and diastolic function in a mouse model of HFpEF?
Does the choice of anesthetic agent (isoflurane vs. Avertin) affect the echocardiographic evaluation of systolic and diastolic function in a mouse model of HFpEF?
Answers are grounded in this paper and cite their sources.
Deep sedation with isoflurane significantly depresses cardiac function in mice, highlighting the need for standardized mild-sedation protocols like Avertin for accurate echocardiographic assessment in translational heart failure research.
Aim: This study aimed to optimize non-invasive echocardiographic evaluation of myocardial function in a mouse model of diastolic heart failure, emphasizing the methodological challenges in assessing diastolic and left atrial (LA) function. Recognizing that clinical human studies frequently assess cardiac performance in non-sedated subjects, this investigation compared systolic and diastolic functional outcomes in mice subjected to heart failure with preserved ejection fraction (HFpEF) using two anesthetic agents: Avertin (mild sedation) and isoflurane (deep sedation). Additionally, we present a histological and echocardiographic correlation of the LA changes in established HFpEF mouse model. Results: Mice received angiotensin II and phenylephrine (AngII/PE) infusions for 28 days, followed by comprehensive echocardiographic and histologic analysis, including advanced diastology and LA assessment. AngII/PE treatment produced a reproducible HFpEF phenotype, with multiorgan involvement. Cardiac function measurements revealed significantly greater declines in both systolic and diastolic function in isoflurane-sedated mice, while mice sedated with Avertin primarily exhibited worsening diastolic metrics. LA histology corroborated imaging findings, showing profound wall thinning, reduced cellularity, and fibrotic conversion by day 28, changes tightly linked to deteriorating diastolic performance. Conclusion: The study highlights the limitations of deep sedation in accurately reflecting physiological cardiac function and underscores the importance of standardized mild-sedation protocols for translational murine heart failure research. Unlike the ventricular thickening and cardiomyocyte hypertrophy typically seen with diastolic dysfunction, LA remodeling was characterized by myocardial thinning and fibrosis, suggesting a distinct and opposite to LV pathogenic process. These findings support prioritizing minimally sedated echocardiographic assessment for better translational relevance.
No takes yet. Share an insight, caveat, or question.
Matsiukevich et al. (2025) studied Heart failure with preserved ejection fraction (HFpEF) (n=16). Isoflurane vs. Avertin (100 mg/kg i.p.) was evaluated on Left ventricular ejection fraction (LV EF) in AngII/PE treated mice (p=<0.0001).
Synapse has enriched 10 related papers. Consider them for comparative context: